INOVIO Reports Inducement Grants Under Inducement Plan
Provided By PR Newswire
Last update: Oct 2, 2024
PLYMOUTH MEETING, Pa., Oct. 2, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made equity grants to certain employees under its 2022 Inducement Plan (the "Inducement Plan").
Read more at prnewswire.com
